The Relevance of Vitamin D and Antinuclear Antibodies in Patients with Inflammatory Bowel Disease Under Anti-TNF Treatment: A Prospective Study

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Inflammatory Bowel Diseases

• Publication date

  2016-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MIB.0000000000000697PMID 26818421
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vitamin D3 levels and bone mineral density in patients with psoriasis and/or psoriatic arthritis

  2015cited by this paper
• Autoimmune hepatitis and anti-tumor necrosis factor alpha therapy: A single center report of 8 cases.

  2015cited by this paper
• Vitamin D is closely linked to the clinical courses of herpes zoster: From pathogenesis to complications.

  2015cited by this paper
• Pretreatment 25-hydroxyvitamin D levels and durability of anti-tumor necrosis factor-α therapy in inflammatory bowel diseases.

  2014cited by this paper
• Serum vitamin D levels are positively associated with varicella zoster immunity in chronic dialysis patients

  2014cited by this paper
• Levels of anti-double-strained DNA but not antinuclear antibodies are associated with treatment efficacy and adverse outcomes in Crohn's disease patients treated with anti-TNFα.

  2013cited by this paper
• The development of arthritis and antinuclear antibodies correlate with serum 25-hydroxyvitamin D levels in patients with leprosy

  2012cited by this paper
• Reduced vitamin D levels are associated with autoimmune response in tuberculosis patients

  2012cited by this paper
• Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus

  2011cited by this paper
• Formation of antinuclear and double‐strand DNA antibodies and frequency of lupus‐like syndrome in anti‐TNF‐&agr; antibody‐treated patients with inflammatory bowel disease

  2011cited by this paper
• Idiopathic itch, rash, and urticaria/angioedema merit serum vitamin D evaluation: a descriptive case series.

  2011cited by this paper
• Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline.

  2011cited by this paper
• Inherited Variation in Vitamin D Genes Is Associated With Predisposition to Autoimmune Disease Type 1 Diabetes

  2011cited by this paper
• Vitamin D deficiency and its association with disease activity in new cases of systemic lupus erythematosus

  2011cited by this paper
• Formation of antinuclear and double strand DNA antibodies and frequency of lupus-like syndrome in anti-TNF-alpha antibody-treated patients with inflammatory bowel disease

  2010influential reference
• Antinuclear antibodies associate with loss of response to antitumour necrosis factor‐α therapy in psoriasis: a retrospective, observational study

  2009cited by this paper
• Vitamin D derivatives induce apoptosis and downregulate ICAM‐1 levels in peripheral blood mononuclear cells of inflammatory bowel disease patients

  2008cited by this paper
• Modulatory Effects of 1,25-Dihydroxyvitamin D3 on Human B Cell Differentiation

  2007cited by this paper
• Cutaneous Manifestations in Inflammatory Bowel Diseases: Eight Cases of Psoriasis Induced by Anti-Tumor-Necrosis-Factor Antibody Therapy

  2007cited by this paper
• Interaction among vitamin D(3) analogue KH 1060, TNF-alpha, and vitamin D receptor protein in peripheral blood mononuclear cells of inflammatory bowel disease patients.

  2006cited by this paper
• Calcium and 1 alpha,25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease.

  2005cited by this paper
• Calcium and 1α,25‐dihydroxyvitamin D3 target the TNF‐α pathway to suppress experimental inflammatory bowel disease

  2005cited by this paper
• Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease: a prospective cohort study.

  2003cited by this paper
• Modulation of TNF‐α expression in bone marrow macrophages: Involvement of vitamin D response element

  2003cited by this paper

• [Prevalence of Hypovitaminosis D in Portugal: A Narrative Review].

  2026cites this paper
• Prevalence and association testing of antinuclear antibodies and inflammatory bowel disease in Taiwan

  2025cites this paper
• Baseline ANA and Anti‐Ro60/SSA Antibody as Potential Predictors for Immunogenicity and Poor EULAR Response in Adalimumab‐Treated RA Patients

  2024cites this paper
• Sex-specific relationship between serum 25-hydroxyvitamin D concentrations and antinuclear antibodies in U.S. adults, NHANES 2001–2004

  2024cites this paper
• Evaluating the predictive effect of vitamin D on clinical outcomes of infliximab-treated Crohn’s disease patients in western China

  2024cites this paper
• Pretreatment Vitamin D Concentrations Do Not Predict Therapeutic Outcome to Anti-TNF Therapies in Biologic-Naïve Patients With Active Luminal Crohn’s Disease

  2023cites this paper
• Predictors and optimal management of tumor necrosis factor antagonist nonresponse in inflammatory bowel disease: A literature review

  2023cites this paper
• The clinical significance of anti-DFS70 autoantibodies and its correlation with Vitamin D levels

  2022cites this paper
• Medicina de precisión en la enfermedad inflamatoria intestinal

  2022cites this paper
• Personalized medicine in inflammatory bowel disease: Perspectives on Asia

  2022cites this paper
• The Role of Vitamin D in Immune System and Inflammatory Bowel Disease

  2022cites this paper
• Pentraxin-3: A Novel Specific Biomarker for Inflammatory Bowel Disease Diagnosis

  2022cites this paper
• Effect of antinuclear antibodies on pharmacokinetics of anti-TNF therapy in patients with inflammatory bowel disease

  2022cites this paper
• Prevalence of antinuclear antibodies in inflammatory bowel disease and seroconversion after biological therapy

  2022cites this paper
• Experiences of Adolescents Who Are Living with Inflammatory Bowel Disease

  2021cites this paper
• Vitamin D-Related Genetics as Predictive Biomarker of Clinical Remission in Adalimumab-Treated Patients Affected by Crohn’s Disease: A Pilot Study

  2021cites this paper
• Early Evidence Indicates Vitamin D Improves Symptoms of Irritable Bowel Syndrome

  2021cites this paper
• Metabolic Influences of Gut Microbiota Dysbiosis on Inflammatory Bowel Disease

  2021cites this paper
• Treatments of inflammatory bowel disease toward personalized medicine

  2021cites this paper
• The role of vitamin D in inflammatory bowel disease: a guide for clinical practice

  2020cites this paper
• Inflammatory bowel disorders and fat-soluble vitamins

  2020cites this paper
• Assessing vitamin D levels in an anti-DFS70 positive population: New insights emerging

  2020cites this paper
• Serum Biomarkers for Inflammatory Bowel Disease

  2020cites this paper
• Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF?

  2020cites this paper
• Vitamin D and inflammatory bowel disease: what do we know so far?

  2020cites this paper
• Precision Medicine: Predicting Disease Course in Patients with Inflammatory Bowel Disease

  2020cites this paper
• British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults

  2019cites this paper
• Associations between inflammatory bowel diseases and vitamin D

  2019cites this paper
• Distinct Association of Serum Vitamin D Concentration with Disease Activity and Trough Levels of Infliximab and Adalimumab during Inflammatory Bowel Disease Treatment

  2019cites this paper
• Vitamin D in inflammatory bowel disease: Biological, clinical and therapeutic aspects.

  2019cites this paper
• Influence of Vitamin D Deficiency on Inflammatory Markers and Clinical Disease Activity in IBD Patients

  2019cites this paper
• Systematic review with meta‐analysis: association of vitamin D status with clinical outcomes in adult patients with inflammatory bowel disease

  2019cites this paper
• European Crohn's and Colitis Organisation Topical Review on Complementary Medicine and Psychotherapy in Inflammatory Bowel Disease.

  2019cites this paper
• Vitamin D in inflammatory bowel disease: From biology to clinical implications.

  2019cites this paper
• Inflammatory bowel disease and immunonutrition: novel therapeutic approaches through modulation of diet and the gut microbiome

  2018cites this paper
• Vitamin D in inflammatory bowel disease: more than just a supplement

  2018cites this paper
• Vitamin D Deficiency in a Portuguese Cohort of Patients with Inflammatory Bowel Disease: Prevalence and Relation to Disease Activity

  2018cites this paper
• VITAMIN D LEVELS AND AUTOIMMUNE DISEASES : A CROSS-SECTIONAL STUDY

  2018cites this paper
• Systematic review: predictive biomarkers of therapeutic response in inflammatory bowel disease—personalised medicine in its infancy

  2018cites this paper
• Role of Vitamin D in Inflammatory Bowel Disease

  2017cites this paper
• AB0966 The clinical observation of immunoadsorption in treatment of children with refractory autoimmune diseases

  2017cites this paper
• Vitamin D inhibits the Staphylococcal enterotoxin B-induced expression of tumor necrosis factor in microglial cells

  2017cites this paper
• Editorial: clinical benefits of vitamin D therapy in inflammatory bowel disease

  2017cites this paper
• Vitamin D inhibits the Staphylococcal enterotoxin B-induced expression of tumor necrosis factor in microglial cells

  2017cites this paper
• Interplay of Immunity and Vitamin D: Interactions and Implications with Current IBD Therapy.

  2017cites this paper
• Vitamin D deficiency as a risk factor for the development of autoantibodies in patients with ASIA and silicone breast implants: a cohort study and review of the literature

  2017cites this paper
• World Journal of Gastroenterology

  year unknowncites this paper